Recent infant-formula safety alerts in the US have renewed concerns about the nutritional quality of products designed for babies. US authorities reported investigations and recalls involving potential microbial contamination, alongside wider testing for heavy metals, pesticides and other chemical contaminants. These developments highlight the importance of ingredient sourcing, manufacturing controls and regulatory oversight.

In India, the issue has taken on added relevance following a September 2026 FSSAI action concerning a sample of follow-up formula that did not meet prescribed biotin (Vitamin B7) requirements on re-analysis. The regulator also initiated separate proceedings over alleged misleading label claims. While nutritional non-compliance is distinct from contamination, both raise questions about product quality, labelling and consumer trust.…